|
|
Incyte Corp. - Comparative Business Analysis Snapshot
Business Description
Incyte Corp.. The Group's principal activities are discovering and developing drugs for the treatment of serious unmet medical needs. The Group is engaged in the development of proprietary small molecule drugs for the treatment of human immunodeficiency virus (HIV), diabetes, oncology and inflammation. The Group operates in the United States, Canada, Germany, Sweden, and the United Kingdom.
Competitor Analysis
This analysis compares Incyte Corp. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
